Prof. Vijay Kuchroo, Samuel Wasserstrom chair of Neurology, and Director of Evergrande center for Immunological Disease at Harvard Medical School and Brigham and Women’s Hospital, Boston (USA) visited Translational Health Science and Technology Institute (THSTI) on 22^nd July, 2022. Prof. Kuchroo is credited with the discovery of the TIM family of molecules, Th17, and other helper T cells subsets. During his visit, he delivered a distinguished lecture on “Role of checkpoint molecular TIM-3 in anti-tumor immunity.” He gave insights into the research that led to discovery of TIM-3. He briefly described the role of TIM-3 in immunology and more specifically its role as a checkpoint molecule in anti-tumor immunity. The lecture was in a hybrid mode and attended by faculty, scientists, and students of THSTI along with participants across India. Prof. Kuchroo emphasized the idea of curiosity and observation as the driving force behind ground-breaking scientific discoveries. The distinguished lecture by Prof. Kuchroo was preceded by scientific presentations and discussions with the immunology group led by Dr. Amit Awasthi.